Parkinson’s Diagnosis Resulted From Regular and Frequent Exposure to Paraquat: Lawsuit

A Mississippi man indicates that years of regular and frequent exposure to Paraquat cased a Parkinson’s diagnosis, which has left him with permanent injuries and disabilities associated with the progressive movement disorder.

The complaint (PDF) was filed by Neil McCord on November 29, indicating that Syngenta Crop Protection, LLC, and Chevron U.S.A., Inc. failed to warn users of the controversial herbicide about the risk of neurological damage, which could cause or contribute to the development of Parkinsonโ€™s disease.

Paraquat has been widely used on farms throughout the United States since the mid-1960s, to control weeds and long grass. However, a growing body of research has established a link between Paraquat and Parkinsonโ€™s diagnosed among farmers and others in the agricultural industry, even when all of the manufacturerโ€™s recommended safety precautions were followed.

According to the lawsuit, McCord used Paraquat as a certified applicator in Mississippi from about 1970 to 1983, indicating that he regularly inhaled, ingested or absorbed Paraquat while using it to desiccate crops for harvest.

โ€œAfter repeated and consistent paraquat exposure, Plaintiff began suffering neurological injuries consistent with Parkinsonโ€™s disease and was diagnosed with Parkinson’s disease in 2018,โ€ McCordโ€™s lawsuit states. โ€œPlaintiffโ€™s neurological injuries have continued and progress over time, and Plaintiff suffers these injuries at present and will continue to suffer these injuries into the future.โ€

The lawsuit notes that while applicators like McCord were told Paraquat was acutely toxic if it was swallowed, they were never told that exposure could cause neurological injuries or Parkinsonโ€™s disease following routine exposure.

McCord only became aware of the Paraquat Parkinsonโ€™s diagnosis risk until the last year, primarily due to the manufacturersโ€™ efforts to conceal those dangers from the public, regulators and even those licensed in its use, the lawsuit states.

Paraquat Parkinson’s Litigation

The case joins dozens of similarย Paraquat Parkinsonโ€™s disease lawsuits now filed in courts throughout the U.S., each raising similar allegations that the manufacturers failed to warn users, even licensed and trained applicators about the risks of Parkinsonโ€™s disease from Paraquat exposure. Many suggest this was in order to keep the already controversial weed killer on the market and thus expand the manufacturersโ€™ profits at the expense of the health of consumers.

While genetics are often believed to be a major cause of Parkinsonโ€™s disease, growing research indicates genes are only believed to be associated with about one-in-ten cases. Exposure to herbicides and pesticides are increasingly considered a leading risk, especially when combined with other factors that place individuals at risk of the development of Parkinsonโ€™s.

Given common questions of fact and law raised in complaints filed throughout the U.S., the federalย Paraquat litigation has been centralizedย before one judge for coordinated discovery and pretrial proceedings. As part of the coordinated federal litigation, a federal judge has indicated that a series of โ€œbellwetherโ€ trials will be held to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the claims.

However, if Paraquat settlements or another resolution for the litigation is not reached, each individual case may later be returned to the home district where it was originally filed for a future trial.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug’s risks but downplayed them to doctors and patients.